Published November 10, 2025 | Version v1
Journal article Open

ЭНДОМЕТРИОЗ-ПУТЬ К БЕСПЛОДИЮ

Authors/Creators

  • 1. Бухарский государственный медицинский институт имени Абу Али ибн Сины, Узбекистан, г. Бухара, ул. А. Навои. 1

Description

X

Files

139-143.pdf

Files (202.8 kB)

Name Size Download all
md5:29f0333196acee7fca72a1504b9fbc6d
202.8 kB Preview Download

Additional details

References

  • Römer T. Long-term treatment of endometriosis with dienogest: retrospective analysis ofefficacy and safety in clinical practice //Archives of gynecology and obstetrics. – 2018. – Т. 298. –№. 4. – С. 747-753. 31. Lee J. H. et al. Effectiveness of dienogest for treatment of recurrent endometriosis: multicenter data //Reproductive Sciences. – 2018. – Т. 25. – №. 10. – С. 1515-1522. 32. Bedaiwy M. A., Allaire C., Alfaraj S. Long-term medical management of endometriosis withdienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy //Fertility and sterility. – 2017. – Т. 107. – №. 3. – С. 537-548. 33. de Paula Andres M. et al. Dienogest in the treatment of endometriosis: systematic review//Archives of gynecology and obstetrics. – 2015. – Т. 292. – №. 3. – С. 523-529. 34. Crosignani P. G. et al. Subcutaneous depot medroxyprogesterone acetate versus leuprolideacetate in the treatment of endometriosis-associated pain //Human Reproduction. – 2006. – Т. 21. – №. 1. – С. 248-256. 35. Hewitt G. D., Gerancher K. R. ACOG COMMITTEE OPINION Number 760 DysmenorrheaandEndometriosis in the Adolescent //OBSTETRICS AND GYNECOLOGY. – 2018. – Т. 132. – №. 6. – С.E249-E258. 36. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29:400–12. 37. Adamson GD, Kennedy S, Hummelshoj L. Creating solutions in endometriosis: globalcollaboration through the World Endometriosis Research Foundation. J Endometr. 2010;2:3–6. 38. Statistics Korea. Daejeon: Statistics Korea; 2019. Outpatient benefits by frequency of disease (total) 2018 38. Soliman AM, Surrey ES, Bonafede M, Nelson JK, Vora JB, Agarwal SK. Health care utilization and costs associated with endometriosis among women with medicaid insurance. J Manag Care Spec Pharm. 2019;25:566–72. 39. Sampson JA. Perforating hemorrhagic (chocolate) cysts of the ovary: their importance and especially their relation to pelvic adenomas of endometrial type ("adenomyoma" of the uterus, rectovaginal septum, sigmoid, etc.) Arch Surg. 1921;3:245–323. 40. Fernando S, Soh PQ, Cooper M, Evans S, Reid G, Tsaltas J, et al. Reliability of visualdiagnosis of endometriosis. J Minim Invasive Gynecol. 2013;20:783–9. 41. Hornstein MD, Gleason RE, Orav J, Haas ST, Friedman AJ, Rein MS, et al. The reproducibility of the revised American Fertility Society classification of endometriosis. Fertil Steril. 1993;59:1015–21. 42. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril. 1996;65:299–304. 43. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospitaldischarge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572–9. 44. Oral E, Ilvan S, Tustas E, Korbeyli B, Bese T, Demirkiran F, et al. Prevalence ofendometriosis in malignant epithelial ovary tumours. Eur J Obstet Gynecol Reprod Biol 2003;109:97–101. 45. Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cystsand endometriosis. Acta Obstet Gynecol Scand 2004;83:395–400. 46. Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, et al. Risk ofdeveloping ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007;17:37–43. 47. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, et al. Infertility,fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002;155:217–24. 48. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausalcancer risk after self-reported endometriosis 49. World Health Organization (WHO). International Classification of Diseases, 11th Revision(ICD-11) Geneva: WHO 2018. 50. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med 2020; 382:1244-56. 51. Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol 2019(4):354-64. 52. Johnson NP, Hummelshoj L, World Endometriosis Society Montpellier Consortium.Consensus on current management of endometriosis. Hum Reprod 2013;28(6):1552-68. 53. Horne AW, Saunders PTK, Abokhrais IM, et al. Top ten endometriosis research priorities inthe UK and Ireland. Lancet 2017; 389:2191-92. 54. Johnson NP, Hummelshoj L, Adamson GD, et al. World Endometriosis Society consensus onthe classification of endometriosis. Hum Reprod 2017;32(2):315-24.